These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 10977389)

  • 1. Handling uncertainty in cost-effectiveness models.
    Briggs AH
    Pharmacoeconomics; 2000 May; 17(5):479-500. PubMed ID: 10977389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decision analytical economic modelling within a Bayesian framework: application to prophylactic antibiotics use for caesarean section.
    Cooper NJ; Sutton AJ; Abrams KR
    Stat Methods Med Res; 2002 Dec; 11(6):491-512. PubMed ID: 12516986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bayesian Solutions for Handling Uncertainty in Survival Extrapolation.
    Negrín MA; Nam J; Briggs AH
    Med Decis Making; 2017 May; 37(4):367-376. PubMed ID: 27281336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An introduction to the methods of cost-effectiveness analysis.
    Drug Ther Bull; 2012 Jul; 50(7):81-4. PubMed ID: 22789768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decision-analytical modelling in health-care economic evaluations.
    Sun X; Faunce T
    Eur J Health Econ; 2008 Nov; 9(4):313-23. PubMed ID: 17943332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An introduction to the methods of decision-analytic modelling used in economic evaluations for Dermatologists.
    McManus E; Sach TH; Levell NJ
    J Eur Acad Dermatol Venereol; 2019 Oct; 33(10):1829-1836. PubMed ID: 31127965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The combined analysis of uncertainty and patient heterogeneity in medical decision models.
    Groot Koerkamp B; Stijnen T; Weinstein MC; Hunink MG
    Med Decis Making; 2011; 31(4):650-61. PubMed ID: 20974904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Bayesian model averaging approach with non-informative priors for cost-effectiveness analyses.
    Conigliani C
    Stat Med; 2010 Jul; 29(16):1696-709. PubMed ID: 20572119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incorporation of statistical uncertainty in health economic modelling studies using second-order Monte Carlo simulations.
    Nuijten MJ
    Pharmacoeconomics; 2004; 22(12):759-69. PubMed ID: 15294010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calibrating models in economic evaluation: a comparison of alternative measures of goodness of fit, parameter search strategies and convergence criteria.
    Karnon J; Vanni T
    Pharmacoeconomics; 2011 Jan; 29(1):51-62. PubMed ID: 21142278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Handling input correlations in pharmacoeconomic models.
    Naveršnik K; Rojnik K
    Value Health; 2012 May; 15(3):540-9. PubMed ID: 22583465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of an economic model to assess the cost effectiveness of asthma management strategies.
    Price MJ; Briggs AH
    Pharmacoeconomics; 2002; 20(3):183-94. PubMed ID: 11929348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probabilistic analysis of cost-effectiveness models: statistical representation of parameter uncertainty.
    Briggs A
    Value Health; 2005; 8(1):1-2. PubMed ID: 15841888
    [No Abstract]   [Full Text] [Related]  

  • 14. Uncertainty in decision models analyzing cost-effectiveness: the joint distribution of incremental costs and effectiveness evaluated with a nonparametric bootstrap method.
    Hunink MG; Bult JR; de Vries J; Weinstein MC
    Med Decis Making; 1998; 18(3):337-46. PubMed ID: 9679999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Methods for analyzing uncertainty].
    Ferriols R; Alós M
    Farm Hosp; 2011 May; 35 Suppl 2():3-9. PubMed ID: 22445503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bayesian approaches to multiple sources of evidence and uncertainty in complex cost-effectiveness modelling.
    Spiegelhalter DJ; Best NG
    Stat Med; 2003 Dec; 22(23):3687-709. PubMed ID: 14652869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An introduction to decision analysis in the economic evaluation of the prevention and treatment of vision-related diseases.
    Kymes SM
    Ophthalmic Epidemiol; 2008; 15(2):76-83. PubMed ID: 18432490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing quality in decision analytic cost-effectiveness models. A suggested framework and example of application.
    Sculpher M; Fenwick E; Claxton K
    Pharmacoeconomics; 2000 May; 17(5):461-77. PubMed ID: 10977388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Buy now, saved later? The critical impact of time-to-pandemic uncertainty on pandemic cost-effectiveness analyses.
    Drake T; Chalabi Z; Coker R
    Health Policy Plan; 2015 Feb; 30(1):100-10. PubMed ID: 24369125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-Effectiveness Uncertainty Analysis Methods: A Comparison of One-Way Sensitivity, Analysis of Covariance, and Expected Value of Partial Perfect Information.
    Campbell JD; McQueen RB; Libby AM; Spackman DE; Carlson JJ; Briggs A
    Med Decis Making; 2015 Jul; 35(5):596-607. PubMed ID: 25349188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.